Browse the latest research summaries in the field of urology for spinal cord injury patients and caregivers.
Showing 271-280 of 407 results
Spinal Cord, 2016 • August 11, 2015
This study evaluated the effectiveness and safety of combined detrusor-trigone BTX-A injections for treating urinary incontinence secondary to neurogenic detrusor overactivity (NDO) in spinal cord inj...
KEY FINDING: BTX-A injections into both the detrusor and trigone muscles resulted in significantly better improvements in I-QoL compared to detrusor-only injections at 12 weeks post-injection.
International Journal of Molecular Sciences, 2015 • August 10, 2015
The evaluation and management of NB includes traditional principles and new technologic progress. There are several promising new treatments for NB, although some treatments are still at the animal ex...
KEY FINDING: Resting-state functional MRI (rs-fMRI) can be used to study the mutual association between the bladder and the brain.
The Journal of Spinal Cord Medicine, 2016 • January 1, 2016
This study aimed to evaluate the relationship between the severity of spinal cord injury (SCI) and neurogenic bladder characteristics, renal calculi, and bladder drainage methods at discharge. The res...
KEY FINDING: Detrusor hyperactivity and compliance were not related to the severity of the spinal cord lesion.
Spinal Cord, 2017 • November 29, 2016
This retrospective study investigated the effect of imidafenacin on urodynamic parameters in SCI patients with indwelling bladder catheters. The study found that imidafenacin significantly improved cy...
KEY FINDING: Imidafenacin increased the cystometric volume from 246.0 to 321.5 ml (median, P = 0.002).
Degenerative Neurological and Neuromuscular Disease, 2014 • March 18, 2014
Neurogenic overactive bladder significantly impacts the lives of individuals with MS and SCI, leading to decreased quality of life and various complications. Traditional treatments for neurogenic over...
KEY FINDING: OnabotulinumtoxinA significantly decreases post-void residuals at 1 month from 251.8 mL to 153.0 mL, and decreases detrusor pressures from 88.7 cm H2O to 20.5 cm H2O.
Topics in Spinal Cord Injury Rehabilitation, 2015 • July 1, 2015
This study investigated sexual function, satisfaction, and aid use in middle-aged adults with long-term physical disabilities. The study aimed to identify factors that contribute to sexual satisfactio...
KEY FINDING: Sexual function was the strongest predictor of sexual satisfaction for both men and women with LTPD.
The Journal of Spinal Cord Medicine, 2019 • September 1, 2019
This study evaluated the efficacy of intravesical lidocaine in preventing autonomic dysreflexia (AD) during routine catheter changes in individuals with spinal cord injury (SCI) at or above T6. The re...
KEY FINDING: Pretreatment with intravesical lidocaine significantly reduced the incidence of AD during catheter changes.
Top Spinal Cord Inj Rehabil, 2015 • July 3, 2015
This retrospective case study examined a series of SCM patients admitted to a spinal rehabilitation service who underwent UDs between January 1, 2000 and June 30, 2010. Sixty-five UD tests were perfor...
KEY FINDING: The most common UD finding was overactive detrusor with no dysynergia (n = 31; 48%), followed by overactive detrusor with sphincter dysynergia (n = 16; 25%) and detrusor areflexia/underactive (n = 12; 18%).
Int Neurourol J, 2016 • December 31, 2016
This study surveyed SCI patients in South Korea to identify factors affecting their quality of life, revealing that urinary and bowel problems, along with sexual dysfunction, are significant concerns ...
KEY FINDING: Urinary problems, particularly incontinence and urinary tract infections, were the most commonly reported issues among SCI patients.
The Journal of Spinal Cord Medicine, 2016 • May 1, 2016
The study retrospectively evaluated the feasibility of reducing intermittent catheterization (IC) frequency from 6/day to 4/day in subacute spinal cord injury (SCI) patients after anticholinergic trea...
KEY FINDING: In 25 of 27 patients, bladder capacity reached 400 ml or more within 45 days of anticholinergic treatment, allowing a shift to 4/day IC.